drugset / Trial / NCT02041247
Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the protective effect of VAC-3S in controlled HIV patients receiving standard of care antiretroviral treatment.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-09
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VAC-3S | Vaccine | 16 ug | Intramuscular |
| Comparator | VAC-3S | Vaccine | 32 ug | Intramuscular |
| Comparator | VAC-3S | Vaccine | 64 ug | Intramuscular |